Role of vitamin D in cognitive function in chronic kidney disease

Nutrients

Volumn 8, Issue 5, 2016, Pages

  Cheng, Zhen ^a,b   Lin, Jing ^b,c   Qian, Qi ^b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b Mayo Clinic   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

Chronic kidney disease; Cognitive impairment; Dialysis; Hypovitaminosis D; Vitamin D

Indexed keywords

CALCIUM CHANNEL L TYPE; COLECALCIFEROL; CYTOKINE; FIBROBLAST GROWTH FACTOR 23; TUMOR NECROSIS FACTOR; TYROSINE 3 MONOOXYGENASE; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

BIOGENESIS; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHRONIC KIDNEY DISEASE; COGNITION; COGNITIVE DEFECT; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; GENETIC POLYMORPHISM; GENETIC RISK; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; INFLAMMATION; META ANALYSIS (TOPIC); MORTALITY; MUSCLE WEAKNESS; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; OSTEOLYSIS; OXIDATIVE STRESS; PLEIOTROPY; PROTEINURIA; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; BLOOD; CHRONIC KIDNEY FAILURE; COGNITIVE DYSFUNCTION; COMPLICATION;

COGNITIVE DYSFUNCTION; HUMANS; RENAL INSUFFICIENCY, CHRONIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84969130610     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8050291     Document Type: Review

References (100)

1. Holick, M.F. Vitamin d deficiency. N. Engl. J. Med. 2007, 357, 266-281. [CrossRef] [PubMed]
2. Coresh, J, Selvin, E, Stevens, L.A, Manzi, J, Kusek, J.W, Eggers, P, Van Lente, F, Levey, A.S. Prevalence of chronic kidney disease in the united states. JAMA 2007, 298, 2038-2047. [CrossRef] [PubMed]
3. Etgen, T, Sander, D, Bickel, H, Sander, K, Forstl, H. Vitamin D deficiency, cognitive impairment and dementia: A systematic review and meta-analysis. Dement. Geriatr. Cogn. Disord. 2012, 33, 297-305. [CrossRef] [PubMed]
4. Kurella Tamura, M, Wadley, V, Yaffe, K, McClure, L.A, Howard, G, Go, R, Allman, R.M, Warnock, D.G, McClellan, W. Kidney function and cognitive impairment in us adults: The reasons for geographic and racial differences in stroke (REGARDS) study. Am. J. Kidney Dis. 2008, 52, 227-234. [CrossRef] [PubMed]
5. Hewison, M, Zehnder, D, Chakraverty, R, Adams, J.S. Vitamin D and barrier function: A novel role for extra-renal 1 alpha-hydroxylase. Mol. Cell. Endocrinol. 2004, 215, 31-38. [CrossRef] [PubMed]
6. Jones, G. Expanding role for vitamin D in chronic kidney disease: Importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3). Semin. Dial. 2007, 20, 316-324. [CrossRef] [PubMed]
7. Al-Badr, W, Martin, K.J. Vitamin D and kidney disease. Clin. J. Am. Soc. Nephrol. 2008, 3, 1555-1560. [CrossRef] [PubMed]
8. Wei, R, Christakos, S. Mechanisms underlying the regulation of innate and adaptive immunity by vitamin D. Nutrients 2015, 7, 8251-8260. [CrossRef] [PubMed]
9. Lowry, M.B, Guo, C, Borregaard, N, Gombart, A.F. Regulation of the human cathelicidin antimicrobial peptide gene by 1alpha,25-dihydroxyvitamin D3 in primary immune cells. J. Steroid Biochem. Mol. Biol. 2014, 143, 183-191. [CrossRef] [PubMed]
10. Heaney, R.P. Vitamin D in health and disease. Clin. J. Am. Soc. Nephrol. 2008, 3, 1535-1541. [CrossRef] [PubMed]
11. Zipitis, C.S, Akobeng, A.K. Vitamin D supplementation in early childhood and risk of type 1 diabetes: A systematic review and meta-analysis. Arch. Dis. Child. 2008, 93, 512-517. [CrossRef] [PubMed]
12. Ranganathan, P, Khalatbari, S, Yalavarthi, S, Marder, W, Brook, R, Kaplan, M.J. Vitamin D deficiency, interleukin 17, and vascular function in rheumatoid arthritis. J. Rheumatol. 2013, 40, 1529-1534. [CrossRef] [PubMed]
13. Summerday, N.M, Brown, S.J, Allington, D.R, Rivey, M.P. Vitamin D and multiple sclerosis: Review of a possible association. J. Pharm. Pract. 2012, 25, 75-84. [CrossRef] [PubMed]
14. Runia, T.F, Hop, W.C, de Rijke, Y.B, Buljevac, D, Hintzen, R.Q. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology 2012, 79, 261-266. [CrossRef] [PubMed]
15. Martineau, A.R, James, W.Y, Hooper, R.L, Barnes, N.C, Jolliffe, D.A, Greiller, C.L, Islam, K, McLaughlin, D, Bhowmik, A, Timms, P.M, et al. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (VIDICO): A multicentre, double-blind, randomised controlled trial. Lancet Respir. Med. 2015, 3, 120-130. [CrossRef]
16. Arnedo-Pena, A, Juan-Cerdan, J.V, Romeu-Garcia, M.A, Garcia-Ferrer, D, Holguin-Gomez, R, Iborra-Millet, J, Pardo-Serrano, F. Vitamin D status and incidence of tuberculosis infection conversion in contacts of pulmonary tuberculosis patients: A prospective cohort study. Epidemiol. Infect. 2015, 143, 1731-1741. [CrossRef] [PubMed]
17. Chen, G.C, Zhang, Z.L, Wan, Z, Wang, L, Weber, P, Eggersdorfer, M, Qin, L.Q, Zhang, W. Circulating 25-hydroxyvitamin D and risk of lung cancer: A dose-response meta-analysis. Cancer Causes Control 2015, 26, 1719-1728. [CrossRef] [PubMed]
18. Chen, P, Li, M, Gu, X, Liu, Y, Li, X, Li, C, Wang, Y, Xie, D, Wang, F, Yu, C, et al. Higher blood 25(OH)D level may reduce the breast cancer risk: Evidence from a Chinese population based case-control study and meta-analysis of the observational studies. PLoS ONE 2013, 8, e49312. [CrossRef] [PubMed]
19. Hollis, B.W. Assessment of circulating 25(OH)D and 1,25(OH)2D: Emergence as clinically important diagnostic tools. Nutr. Rev. 2007, 65, S87-S90. [CrossRef] [PubMed]
20. Hollis, B.W. Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr. Opin. Endocrinol. Diabetes Obes. 2008, 15, 489-494. [CrossRef] [PubMed]
21. Zittermann, A, Iodice, S, Pilz, S, Grant, W.B, Bagnardi, V, Gandini, S. Vitamin D deficiency and mortality risk in the general population: A meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 2012, 95, 91-100. [CrossRef] [PubMed]
22. Chonchol, M, Kendrick, J, Targher, G. Extra-skeletal effects of vitamin D deficiency in chronic kidney disease. Ann. Med. 2011, 43, 273-282. [CrossRef] [PubMed]
23. Chowdhury, R, Kunutsor, S, Vitezova, A, Oliver-Williams, C, Chowdhury, S, Kiefte-de-Jong, J.C, Khan, H, Baena, C.P, Prabhakaran, D, Hoshen, M.B, et al. Vitamin D and risk of cause specific death: Systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014, 348, g1903. [CrossRef] [PubMed]
24. Arabi, A, El Rassi, R, El-Hajj Fuleihan, G. Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat. Rev. Endocrinol. 2010, 6, 550-561. [CrossRef] [PubMed]
25. Bassil, D, Rahme, M, Hoteit, M, Fuleihan Gel, H. Hypovitaminosis D in the Middle East and North Africa: Prevalence, risk factors and impact on outcomes. Dermatoendocrinology 2013, 5, 274-298. [CrossRef] [PubMed]
26. Holick, M.F, Binkley, N.C, Bischoff-Ferrari, H.A, Gordon, C.M, Hanley, D.A, Heaney, R.P, Murad, M.H, Weaver, C.M, Endocrine, S. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96, 1911-1930. [CrossRef] [PubMed]
27. Kelishadi, R, Moeini, R, Poursafa, P, Farajian, S, Yousefy, H, Okhovat-Souraki, A.A. Independent association between air pollutants and vitamin D deficiency in young children in isfahan, Iran. Paediatr. Int. Child Health 2014, 34, 50-55. [CrossRef] [PubMed]
28. Hosseinpanah, F, Pour, S.H, Heibatollahi, M, Moghbel, N, Asefzade, S, Azizi, F. The effects of air pollution on vitamin D status in healthy women: A cross sectional study. BMC Public Health 2010, 10, 519. [CrossRef] [PubMed]
29. Calderon-Garciduenas, L, Franco-Lira, M, D’Angiulli, A, Rodriguez-Diaz, J, Blaurock-Busch, E, Busch, Y, Chao, C.K, Thompson, C, Mukherjee, P.S, Torres-Jardon, R, et al. Mexico City normal weight children exposed to high concentrations of ambient PM 2.5 show high blood leptin and endothelin-1, vitamin D deficiency, and food reward hormone dysregulation versus low pollution controls. Relevance for obesity and Alzheimer disease. Environ. Res. 2015, 140, 579-592. [PubMed]
30. Ahn, J, Yu, K, Stolzenberg-Solomon, R, Simon, K.C, McCullough, M.L, Gallicchio, L, Jacobs, E.J, Ascherio, A, Helzlsouer, K, Jacobs, K.B, et al. Genome-wide association study of circulating vitamin D levels. Hum. Mol. Genet. 2010, 19, 2739-2745. [CrossRef] [PubMed]
31. Shea, M.K, Benjamin, E.J, Dupuis, J, Massaro, J.M, Jacques, P.F, D’Agostino, R.B., Sr, Ordovas, J.M, O’Donnell, C.J, Dawson-Hughes, B, Vasan, R.S, et al. Genetic and non-genetic correlates of vitamins K and D. Eur. J. Clin. Nutr. 2009, 63, 458-464. [CrossRef] [PubMed]
32. Wang, T.J, Zhang, F, Richards, J.B, Kestenbaum, B, van Meurs, J.B, Berry, D, Kiel, D.P, Streeten, E.A, Ohlsson, C, Koller, D.L, et al. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet 2010, 376, 180-188. [CrossRef]
33. Schöttker, B, Jorde, R, Peasey, A, Thorand, B, Jansen, E.H, Groot, L, Streppel, M, Gardiner, J, Ordonez-Mena, J.M, Perna, L, et al. Vitamin D and mortality: Meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 2014, 348, g3656. [CrossRef] [PubMed]
34. Borel, P, Caillaud, D, Cano, N.J. Vitamin D bioavailability: State of the art. Crit. Rev. Food Sci. Nutr. 2015, 55, 1193-1205. [CrossRef] [PubMed]
35. Wang, L, Manson, J.E, Song, Y, Sesso, H.D. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann. Intern. Med. 2010, 152, 315-323. [CrossRef] [PubMed]
36. Rossom, R.C, Espeland, M.A, Manson, J.E, Dysken, M.W, Johnson, K.C, Lane, D.S, LeBlanc, E.S, Lederle, F.A, Masaki, K.H, Margolis, K.L. Calcium and vitamin D supplementation and cognitive impairment in the women’s health initiative. J. Am. Geriatr. Soc. 2012, 60, 2197-2205. [CrossRef] [PubMed]
37. Echida, Y, Mochizuki, T, Uchida, K, Tsuchiya, K, Nitta, K. Risk factors for vitamin D deficiency in patients with chronic kidney disease. Intern. Med. 2012, 51, 845-850. [CrossRef] [PubMed]
38. Krajisnik, T, Bjorklund, P, Marsell, R, Ljunggren, O, Akerstrom, G, Jonsson, K.B, Westin, G, Larsson, T.E. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J. Endocrinol. 2007, 195, 125-131. [CrossRef] [PubMed]
39. Hasegawa, H, Nagano, N, Urakawa, I, Yamazaki, Y, Iijima, K, Fujita, T, Yamashita, T, Fukumoto, S, Shimada, T. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int. 2010, 78, 975-980. [CrossRef] [PubMed]
40. Sato, K.A, Gray, R.W, Lemann, J., Jr. Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome. J. Lab. Clin. Med. 1982, 99, 325-330. [PubMed]
41. Jacob, A.I, Sallman, A, Santiz, Z, Hollis, B.W. Defective photoproduction of cholecalciferol in normal and uremic humans. J. Nutr. 1984, 114, 1313-1319. [PubMed]
42. Tsiaras, W.G, Weinstock, M.A. Factors influencing vitamin D status. Acta Derm. Venereol. 2011, 91, 115-124. [CrossRef] [PubMed]
43. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. Suppl. 2009, 113, S1-S130.
44. Kim, S.M, Choi, H.J, Lee, J.P, Kim, D.K, Oh, Y.K, Kim, Y.S, Lim, C.S. Prevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney disease. J. Ren. Nutr. 2014, 24, 20-25. [CrossRef] [PubMed]
45. Fukuda, N, Tanaka, H, Tominaga, Y, Fukagawa, M, Kurokawa, K, Seino, Y. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J. Clin. Investig. 1993, 92, 1436-1443. [CrossRef] [PubMed]
46. Nigwekar, S.U, Bhan, I, Thadhani, R. Ergocalciferol and cholecalciferol in CKD. Am. J. Kidney Dis. 2012, 60, 139-156. [CrossRef] [PubMed]
47. Hsu, C.H, Patel, S.R. Altered vitamin D metabolism and receptor interaction with the target genes in renal failure: Calcitriol receptor interaction with its target gene in renal failure. Curr. Opin. Nephrol. Hypertens. 1995, 4, 302-306. [CrossRef] [PubMed]
48. Patel, S.R, Ke, H.Q, Vanholder, R, Koenig, R.J, Hsu, C.H. Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J. Clin. Investig. 1995, 96, 50-59. [CrossRef] [PubMed]
49. Pilz, S, Iodice, S, Zittermann, A, Grant, W.B, Gandini, S. Vitamin D status and mortality risk in CKD: A meta-analysis of prospective studies. Am. J. Kidney Dis. 2011, 58, 374-382. [CrossRef] [PubMed]
50. Zheng, Z, Shi, H, Jia, J, Li, D, Lin, S. Vitamin D supplementation and mortality risk in chronic kidney disease: A meta-analysis of 20 observational studies. BMC Nephrol. 2013, 14, 199. [CrossRef] [PubMed]
51. Duranton, F, Rodriguez-Ortiz, M.E, Duny, Y, Rodriguez, M, Daures, J.P, Argiles, A. Vitamin D treatment and mortality in chronic kidney disease: A systematic review and meta-analysis. Am. J. Nephrol. 2013, 37, 239-248. [CrossRef] [PubMed]
52. Xu, L, Wan, X, Huang, Z, Zeng, F, Wei, G, Fang, D, Deng, W, Li, Y. Impact of vitamin D on chronic kidney diseases in non-dialysis patients: A meta-analysis of randomized controlled trials. PLoS ONE 2013, 8, e61387. [CrossRef] [PubMed]
53. Palmer, S.C, McGregor, D.O, Macaskill, P, Craig, J.C, Elder, G.J, Strippoli, G.F. Meta-analysis: Vitamin D compounds in chronic kidney disease. Ann. Intern. Med. 2007, 147, 840-853. [CrossRef] [PubMed]
54. Mann, M.C, Hobbs, A.J, Hemmelgarn, B.R, Roberts, D.J, Ahmed, S.B, Rabi, D.M. Effect of oral vitamin D analogs on mortality and cardiovascular outcomes among adults with chronic kidney disease: A meta-analysis. Clin. Kidney J. 2015, 8, 41-48. [CrossRef] [PubMed]
55. Annweiler, C, Dursun, E, Feron, F, Gezen-Ak, D, Kalueff, A.V, Littlejohns, T, Llewellyn, D.J, Millet, P, Scott, T, Tucker, K.L, et al. Vitamin D and cognition in older adults": Updated international recommendations. J. Intern. Med. 2015, 277, 45-57. [CrossRef] [PubMed]
56. Prufer, K, Veenstra, T.D, Jirikowski, G.F, Kumar, R. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J. Chem. Neuroanat. 1999, 16, 135-145. [CrossRef]
57. Eyles, D.W, Smith, S, Kinobe, R, Hewison, M, McGrath, J.J. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J. Chem. Neuroanat. 2005, 29, 21-30. [CrossRef] [PubMed]
58. Garcion, E, Wion-Barbot, N, Montero-Menei, C.N, Berger, F, Wion, D. New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab. 2002, 13, 100-105. [CrossRef]
59. Smith, M.P, Fletcher-Turner, A, Yurek, D.M, Cass, W.A. Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochem. Res. 2006, 31, 533-539. [CrossRef] [PubMed]
60. Garcion, E, Nataf, S, Berod, A, Darcy, F, Brachet, P. 1,25-dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res. Mol. Brain Res. 1997, 45, 255-267. [CrossRef]
61. Baas, D, Prufer, K, Ittel, M.E, Kuchler-Bopp, S, Labourdette, G, Sarlieve, L.L, Brachet, P. Rat oligodendrocytes express the vitamin D(3) receptor and respond to 1,25-dihydroxyvitamin D(3). Glia 2000, 31, 59-68. [CrossRef]
62. Li, L, Prabhakaran, K, Zhang, X, Zhang, L, Liu, H, Borowitz, J.L, Isom, G.E. 1alpha,25-dihydroxyvitamin D3 attenuates cyanide-induced neurotoxicity by inhibiting uncoupling protein-2 up-regulation. J. Neurosci. Res. 2008, 86, 1397-1408. [CrossRef] [PubMed]
63. Brewer, L.D, Thibault, V, Chen, K.C, Langub, M.C, Landfield, P.W, Porter, N.M. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J. Neurosci. 2001, 21, 98-108. [PubMed]
64. Taniura, H, Ito, M, Sanada, N, Kuramoto, N, Ohno, Y, Nakamichi, N, Yoneda, Y. Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mrna expression in cultured rat cortical neurons. J. Neurosci. Res. 2006, 83, 1179-1189. [CrossRef] [PubMed]
65. Wang, J.Y, Wu, J.N, Cherng, T.L, Hoffer, B.J, Chen, H.H, Borlongan, C.V, Wang, Y. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res. 2001, 904, 67-75. [CrossRef]
66. Wang, L, Hara, K, Van Baaren, J.M, Price, J.C, Beecham, G.W, Gallins, P.J, Whitehead, P.L, Wang, G, Lu, C, Slifer, M.A, et al. Vitamin D receptor and alzheimer’s disease: A genetic and functional study. Neurobiol. Aging 2012, 33, e1-e9. [CrossRef] [PubMed]
67. Grimm, M.O, Lehmann, J, Mett, J, Zimmer, V.C, Grosgen, S, Stahlmann, C.P, Hundsdorfer, B, Haupenthal, V.J, Rothhaar, T.L, Herr, C, et al. Impact of vitamin D on amyloid precursor protein processing and amyloid-beta peptide degradation in Alzheimer’s disease. Neurodegener. Dis. 2014, 13, 75-81. [CrossRef] [PubMed]
68. Almeras, L, Eyles, D, Benech, P, Laffite, D, Villard, C, Patatian, A, Boucraut, J, Mackay-Sim, A, McGrath, J, Feron, F. Developmental vitamin D deficiency alters brain protein expression in the adult rat: Implications for neuropsychiatric disorders. Proteomics 2007, 7, 769-780. [CrossRef] [PubMed]
69. Bartley, J. Vitamin D: Emerging roles in infection and immunity. Expert Rev. Anti-Infect. Ther. 2010, 8, 1359-1369. [CrossRef] [PubMed]
70. Maddock, J, Cavadino, A, Power, C, Hypponen, E. 25-hydroxyvitamin D, APOE varepsilon4 genotype and cognitive function: Findings from the 1958 British birth cohort. Eur. J. Clin. Nutr. 2015, 69, 505-508. [CrossRef] [PubMed]
71. Teng, E.L, Chui, H.C. The Modified Mini-Mental State (3MS) examination. J. Clin. Psychiatry 1987, 48, 314-318. [PubMed]
72. Schneider, S.M, Kielstein, J.T, Braverman, J, Novak, M. Cognitive function in patients with chronic kidney disease: Challenges in neuropsychological assessments. Semin. Nephrol. 2015, 35, 304-310. [CrossRef] [PubMed]
73. Balion, C, Griffith, L.E, Strifler, L, Henderson, M, Patterson, C, Heckman, G, Llewellyn, D.J, Raina, P. Vitamin D, cognition, and dementia: A systematic review and meta-analysis. Neurology 2012, 79, 1397-1405. [CrossRef] [PubMed]
74. Llewellyn, D.J, Lang, I.A, Langa, K.M, Muniz-Terrera, G, Phillips, C.L, Cherubini, A, Ferrucci, L, Melzer, D. Vitamin D and risk of cognitive decline in elderly persons. Arch. Intern. Med. 2010, 170, 1135-1141. [CrossRef] [PubMed]
75. Kurella Tamura, M, Muntner, P, Wadley, V, Cushman, M, Zakai, N.A, Bradbury, B.D, Kissela, B, Unverzagt, F, Howard, G, Warnock, D, et al. Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. Am. J. Kidney Dis. 2011, 58, 756-763. [CrossRef] [PubMed]
76. Kurella, M, Chertow, G.M, Fried, L.F, Cummings, S.R, Harris, T, Simonsick, E, Satterfield, S, Ayonayon, H, Yaffe, K. Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study. J. Am. Soc. Nephrol. 2005, 16, 2127-2133. [CrossRef] [PubMed]
77. Etgen, T, Chonchol, M, Forstl, H, Sander, D. Chronic kidney disease and cognitive impairment: A systematic review and meta-analysis. Am. J. Nephrol. 2012, 35, 474-482. [CrossRef] [PubMed]
78. Shin, M.H, Kweon, S.S, Choi, J.S, Lee, Y.H, Nam, H.S, Park, K.S, Kim, H.N, Oh, S.Y, Jeong, S.K. A disease modification effect of APOE E4 on the association between urinary albumin excretion and cognition in Korean adults. Dis. Markers 2014, 2014, 724281. [CrossRef] [PubMed]
79. Kurella, M, Chertow, G.M, Luan, J, Yaffe, K. Cognitive impairment in chronic kidney disease. J. Am. Geriatr. Soc. 2004, 52, 1863-1869. [CrossRef] [PubMed]
80. Kurella Tamura, M, Larive, B, Unruh, M.L, Stokes, J.B, Nissenson, A, Mehta, R.L, Chertow, G.M. Prevalence and correlates of cognitive impairment in hemodialysis patients: The frequent hemodialysis network trials. Clin. J. Am. Soc. Nephrol. 2010, 5, 1429-1438. [CrossRef] [PubMed]
81. Yaffe, K, Ackerson, L, Kurella Tamura, M, Le Blanc, P, Kusek, J.W, Sehgal, A.R, Cohen, D, Anderson, C, Appel, L, Desalvo, K, et al. Chronic kidney disease and cognitive function in older adults: Findings from the chronic renal insufficiency cohort cognitive study. J. Am. Geriatr. Soc. 2010, 58, 338-345. [CrossRef] [PubMed]
82. Griva, K, Stygall, J, Hankins, M, Davenport, A, Harrison, M, Newman, S.P. Cognitive impairment and 7-year mortality in dialysis patients. Am. J. Kidney Dis. 2010, 56, 693-703. [CrossRef] [PubMed]
83. Gupta, J, Mitra, N, Kanetsky, P.A, Devaney, J, Wing, M.R, Reilly, M, Shah, V.O, Balakrishnan, V.S, Guzman, N.J, Girndt, M, et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin. J. Am. Soc. Nephrol. 2012, 7, 1938-1946. [CrossRef] [PubMed]
84. Stenvinkel, P, Heimburger, O, Paultre, F, Diczfalusy, U, Wang, T, Berglund, L, Jogestrand, T. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999, 55, 1899-1911. [CrossRef] [PubMed]
85. Anagnostis, P, Athyros, V.G, Adamidou, F, Florentin, M, Karagiannis, A. Vitamin D and cardiovascular disease: A novel agent for reducing cardiovascular risk? Curr. Vasc. Pharmacol. 2010, 8, 720-730. [CrossRef] [PubMed]
86. Kurella, M, Mapes, D.L, Port, F.K, Chertow, G.M. Correlates and outcomes of dementia among dialysis patients: The dialysis outcomes and practice patterns study. Nephrol. Dial. Transplant. 2006, 21, 2543-2548. [CrossRef] [PubMed]
87. Sarnak, M.J, Tighiouart, H, Scott, T.M, Lou, K.V, Sorensen, E.P, Giang, L.M, Drew, D.A, Shaffi, K, Strom, J.A, Singh, A.K, et al. Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology 2013, 80, 471-480. [CrossRef] [PubMed]
88. Kurella Tamura, M, Yaffe, K, Hsu, C.Y, Yang, J, Sozio, S, Fischer, M, Chen, J, Ojo, A, DeLuca, J, Xie, D, et al. Cognitive impairment and progression of CKD. Am. J. Kidney Dis. 2016. [CrossRef] [PubMed]
89. Palmer, S.C, Ruospo, M, Barulli, M.R, Iurillo, A, Saglimbene, V, Natale, P, Gargano, L, Murgo, A.M, Loy, C, van Zwieten, A, et al. COGNITIVE-HD study: Protocol of an observational study of neurocognitive functioning and association with clinical outcomes in adults with end-stage kidney disease treated with haemodialysis. BMJ Open 2015, 5, e009328. [CrossRef] [PubMed]
90. Shaffi, K, Tighiouart, H, Scott, T, Lou, K, Drew, D, Weiner, D, Sarnak, M. Low 25-hydroxyvitamin D levels and cognitive impairment in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 2013, 8, 979-986. [CrossRef] [PubMed]
91. Liu, G.L, Pi, H.C, Hao, L, Li, D.D, Wu, Y.G, Dong, J. Vitamin D status is an independent risk factor for global cognitive impairment in peritoneal dialysis patients. PLoS ONE 2015, 10, e0143782. [CrossRef] [PubMed]
92. Jovanovich, A.J, Chonchol, M, Brady, C.B, Kaufman, J.D, Kendrick, J, Cheung, A.K, Jablonski, K.L. 25-vitamin D, 1,25-vitamin D, parathyroid hormone, fibroblast growth factor-23 and cognitive function in men with advanced CKD: A veteran population. Clin. Nephrol. 2014, 82, 296-303. [CrossRef] [PubMed]
93. Miller, J.W, Harvey, D.J, Beckett, L.A, Green, R, Farias, S.T, Reed, B.R, Olichney, J.M, Mungas, D.M, DeCarli, C. Vitamin D status and rates of cognitive decline in a multiethnic cohort of older adults. JAMA Neurol. 2015, 72, 1295-1303. [CrossRef] [PubMed]
94. National Institutes of Health: Vitamin D Supplementation on Physical and Cognitive Function-Pilot Study. Available online: https://clinicaltrials.gov/ct2/show/NCT01229878 (accessed on 16 February 2016).
95. Romijn, M.D, van Marum, R.J, Emmelot-Vonk, M.H, Verhaar, H.J, Koek, H.L. Mild chronic kidney disease is associated with cognitive function in patients presenting at a memory clinic. Int. J. Geriatr. Psychiatry 2015, 30, 758-765. [CrossRef] [PubMed]
96. Callahan, C.M, Unverzagt, F.W, Hui, S.L, Perkins, A.J, Hendrie, H.C. Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med. Care 2002, 40, 771-781. [CrossRef] [PubMed]
97. Tiffin-Richards, F.E, Costa, A.S, Holschbach, B, Frank, R.D, Vassiliadou, A, Kruger, T, Kuckuck, K, Gross, T, Eitner, F, Floege, J, et al. The montreal cognitive assessment (MOCA)-A sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. PLoS ONE 2014, 9, e106700.
98. Siew, E.D, Ikizler, T.A. Determinants of insulin resistance and its effects on protein metabolism in patients with advanced chronic kidney disease. Contrib. Nephrol. 2008, 161, 138-144. [PubMed]
99. Glade, M.J. A 21st century evaluation of the safety of oral vitamin D. Nutrition 2012, 28, 344-356. [CrossRef] [PubMed]
100. Kusunoki, Y, Matsui, I, Hamano, T, Shimomura, A, Mori, D, Yonemoto, S, Takabatake, Y, Tsubakihara, Y, St-Arnaud, R, Isaka, Y, et al. Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury in mice by modulating macrophage phenotype. Kidney Int. 2015, 88, 1013-1029. [CrossRef] [PubMed]